Clorox Co (NYSE:CLX) has earned a consensus recommendation of “Hold” from the fifteen research firms that are presently covering the stock, MarketBeat.com reports. Five research analysts have rated the stock with a sell recommendation, eight have assigned a hold recommendation and two have given a buy recommendation to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $152.17.
A number of analysts have weighed in on CLX shares. UBS Group dropped their target price on shares of Clorox from $128.00 to $125.00 and set a “sell” rating on the stock in a report on Thursday, October 3rd. JPMorgan Chase & Co. reaffirmed an “underweight” rating and issued a $137.00 price objective (down previously from $143.00) on shares of Clorox in a report on Thursday, October 3rd. Credit Suisse Group dropped their price objective on shares of Clorox from $172.00 to $168.00 and set an “outperform” rating on the stock in a report on Thursday, October 3rd. Cfra cut shares of Clorox from a “hold” rating to a “sell” rating in a report on Friday, November 1st. Finally, Morgan Stanley reaffirmed an “underweight” rating and issued a $134.00 price objective (down previously from $144.00) on shares of Clorox in a report on Monday, September 30th.
In other news, SVP Denise Garner sold 725 shares of the firm’s stock in a transaction dated Friday, November 22nd. The shares were sold at an average price of $146.34, for a total transaction of $106,096.50. Following the completion of the transaction, the senior vice president now owns 5,805 shares in the company, valued at approximately $849,503.70. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Andrew J. Mowery sold 5,648 shares of the firm’s stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $146.29, for a total transaction of $826,245.92. Following the transaction, the senior vice president now owns 15,920 shares of the company’s stock, valued at approximately $2,328,936.80. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.
Several large investors have recently bought and sold shares of CLX. Strategic Blueprint LLC bought a new position in shares of Clorox during the 3rd quarter valued at about $37,000. Transamerica Financial Advisors Inc. acquired a new position in shares of Clorox in the second quarter worth about $41,000. Usca Ria LLC acquired a new position in shares of Clorox in the third quarter worth about $41,000. Mirova acquired a new position in shares of Clorox in the second quarter worth about $47,000. Finally, Wealthcare Advisory Partners LLC boosted its holdings in shares of Clorox by 48.3% in the third quarter. Wealthcare Advisory Partners LLC now owns 307 shares of the company’s stock worth $47,000 after buying an additional 100 shares during the period. Institutional investors own 77.64% of the company’s stock.
Shares of NYSE:CLX traded up $0.07 on Friday, reaching $152.05. 15,183 shares of the company’s stock were exchanged, compared to its average volume of 767,837. The firm has a market capitalization of $19.02 billion, a price-to-earnings ratio of 24.06, a PEG ratio of 4.84 and a beta of 0.39. Clorox has a fifty-two week low of $143.58 and a fifty-two week high of $166.90. The business’s 50-day moving average is $150.88 and its two-hundred day moving average is $153.81. The company has a quick ratio of 0.52, a current ratio of 0.87 and a debt-to-equity ratio of 4.69.
Clorox (NYSE:CLX) last issued its earnings results on Thursday, October 31st. The company reported $1.59 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.54 by $0.05. The company had revenue of $1.51 billion for the quarter, compared to analysts’ expectations of $1.51 billion. Clorox had a net margin of 13.20% and a return on equity of 123.56%. The firm’s revenue was down 3.6% compared to the same quarter last year. During the same period in the prior year, the company earned $1.62 earnings per share. Analysts predict that Clorox will post 6.16 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a $1.06 dividend. The ex-dividend date is Tuesday, January 28th. This represents a $4.24 dividend on an annualized basis and a yield of 2.79%. Clorox’s dividend payout ratio is presently 67.09%.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Article: What is the Consumer Price Index (CPI)?
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.